Genetic Aberrations and Subclonal Structure Impact Chronic Lymphocytic Leukemia

ANALYTE_TYPE - Analyte Type (phv00252630.v2.p1)
BODY_SITE - Body site where sample was collected (phv00491115.v1.p1)
CONSENT - Consent group as determined by DAC (phv00252622.v2.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00491116.v1.p1)
IS_TUMOR - Tumor status (phv00252629.v2.p1)
PRIMARY_DISEASE - The main disease(s) for which the participant has been asked to donate a sample for study (phv00252627.v2.p1)
PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00491117.v1.p1)
SAMPLE_ID - Sample ID (phv00252628.v2.p1)
SAMPLE_ID - Sample ID (phv00252623.v2.p1)
SEQUENCING_CENTER - Where samples were sequenced (phv00491118.v1.p1)
SUBJECT_ID - Subject ID (phv00252621.v2.p1)
SUBJECT_ID - Subject ID (phv00252624.v2.p1)
SUBJECT_ID - Subject ID (phv00252626.v2.p1)